OpenAlex
PricingAboutJobs
Log inGet started
Work

Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta -amyloid peptide em in vitro em and in patients

HTML

Year: 2002
Type: article
Study design: Clinical Trial
Source: Frontiers in bioscience
DOI: 10.2741/a739
Authors: Joseph D Buxbaum, Edward I Cullen, Lawrence T Friedhoff
Institutions: Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: lovastatin, statins, Alzheimer's disease, beta-amyloid peptide, hypercholesterolemia, cholesterol, LDL cholesterol, statin therapy, dose-dependent effects
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Aging
Awards: Interdisciplinary Approach to Alzheimer Drug Discovery, Clinical and Biological Studies of Early AD
OpenAlex ID: W281248207
FWCI: 2.763
Cites: 26
Cited by: 94
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security